236 related articles for article (PubMed ID: 32812860)
1. Establishment of a Rep' protein antibody detection method to distinguish natural infection with PCV2 from subunit vaccine immunization.
Chen Q; Rong J; Li G; Xu B; Wang X; Hu J; Rong M; Li H
J Med Microbiol; 2020 Sep; 69(9):1183-1196. PubMed ID: 32812860
[No Abstract] [Full Text] [Related]
2. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
3. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
4. A nanobody-horseradish peroxidase fusion protein-based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2.
Mu Y; Jia C; Zheng X; Zhu H; Zhang X; Xu H; Liu B; Zhao Q; Zhou EM
J Nanobiotechnology; 2021 Feb; 19(1):34. PubMed ID: 33526021
[TBL] [Abstract][Full Text] [Related]
5. Establishment and application of a competitive enzyme-linked immunosorbent assay differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera.
Han S; Xiao Y; Zheng D; Gu Y; Xuan Y; Jin Y; Pang W; Huang Y; Li X; Deng J; Tian K
BMC Vet Res; 2016 Aug; 12(1):175. PubMed ID: 27561335
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
7. [Immune efficacy in mice by recombinant pseudorabies virus PGO expressing ORF2 gene of porcine circovirus type 2].
Chao A; Fu P; Guo X; Gao X; Cui B; Chen H
Wei Sheng Wu Xue Bao; 2014 Feb; 54(2):211-7. PubMed ID: 24818470
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity of a recombinant pseudorabies virus coexpressing ORF2 gene of PCV2 and porcine IL-18 gene in mice].
Guo X; Zhu Q; Pan X; Yang X; Qiao H; Wang S; Chen H
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):120-9. PubMed ID: 27305786
[TBL] [Abstract][Full Text] [Related]
9. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
10. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
11. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
[TBL] [Abstract][Full Text] [Related]
14. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
15. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice.
Liu X; Ouyang T; Ma T; Ouyang H; Pang D; Ren L
BMC Vet Res; 2018 Apr; 14(1):137. PubMed ID: 29685143
[TBL] [Abstract][Full Text] [Related]
17. A comparative efficacy test of 1
Do DT; Tran KDV; Quach AT; Lee D; Chang FC; Wu CP; Tat TN; Chae C
Can J Vet Res; 2021 Apr; 85(2):93-100. PubMed ID: 33883815
[TBL] [Abstract][Full Text] [Related]
18. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
[TBL] [Abstract][Full Text] [Related]
19. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
20. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis.
Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM
Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
